Galectin-3 restricts dengue virus infection through glycan-dependent envelope binding and enhances NF-κB signaling

Abstract Background No antiviral therapy is approved for dengue virus (DENV). Galectin-3 (Gal3), a β-galactoside-binding lectin, modulates several viral infections, but its role in DENV pathogenesis is unknown. Material and Methods Using a GFP-tagged DENV-2 reporter virus, we evaluated the effects of recombinant Gal3, Gal3 knockdown and Gal3 overexpression. Viral attachment, internalization, NF-κB signaling and cytokine expression were analyzed, together with molecular docking of Gal3 to the DENV envelope (E) protein. Disease outcomes were assessed in intracerebrally inoculated neonatal Gal3-knockout (Gal3-KO) mice. Results DENV-2 infection down-regulated endogenous Gal3. Extracellularly, recombinant Gal3 reduced DENV-2 infectivity and progeny production in a dose-dependent manner, and conditioned medium containing cell-secreted Gal3 had a similar effect. The inhibition was reversed by lactose, and by the Gal3-neutralizing antibody B2C10, but not by sucrose or control IgG. Gal3 bound the E protein and reduced viral attachment and internalization. In silico docking was compatible with Gal3 engagement at both E glycosylation sites, with aggregate scores favoring Asn67. Knockdown of endogenous Gal3 enhanced, and overexpression suppressed, DENV-2 replication. Gal3 also amplified NF-κB activation and the expression of IL-6, IL-8, TNF-α and IL-1β, without altering type I interferon transcripts. In vivo , infected Gal3-KO neonates showed earlier mortality, higher brain viral loads and more severe neuropathology than wild-type mice. Conclusions Gal3 restricts DENV-2 by binding the viral envelope glycoprotein and reducing viral entry, and by enhancing NF-κB-dependent pro-inflammatory responses. Gal3 deficiency worsens disease in vivo , and Gal3 is a candidate host-directed target against dengue.

Authors

Publication Details

Journal
Virology Journal
Published
2026-11-15
DOI
https://doi.org/10.1186/s12985-026-03362-4
Primary Topic
Galectins and Cancer Biology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Galectin-3 restricts dengue virus infection through glycan-dependent envelope binding and enhances NF-κB signaling

Wanchai Assavalapsakul, Zih‐Syuan Yang, Arunee Thitithanyanont, Yun-Tzu Hsu et al.
Virology Journal
Galectins and Cancer Biology
article

Galectin-3 restricts dengue virus infection through glycan-dependent envelope binding and enhances NF-κB signaling

Wanchai Assavalapsakul, Zih‐Syuan Yang, Arunee Thitithanyanont, Yun-Tzu Hsu, Albright Dew Baua, Pin-Chen Chen, Yen-Hsu Chen, Day-Yu Chao, Sheng-Fan Wang, Chun-Yu Lin, Wen-Hung Wang
article en

Abstract

Abstract Background No antiviral therapy is approved for dengue virus (DENV). Galectin-3 (Gal3), a β-galactoside-binding lectin, modulates several viral infections, but its role in DENV pathogenesis is unknown. Material and Methods Using a GFP-tagged DENV-2 reporter virus, we evaluated the effects of recombinant Gal3, Gal3 knockdown and Gal3 overexpression. Viral attachment, internalization, NF-κB signaling and cytokine expression were analyzed, together with molecular docking of Gal3 to the DENV envelope (E) protein. Disease outcomes were assessed in intracerebrally inoculated neonatal Gal3-knockout (Gal3-KO) mice. Results DENV-2 infection down-regulated endogenous Gal3. Extracellularly, recombinant Gal3 reduced DENV-2 infectivity and progeny production in a dose-dependent manner, and conditioned medium containing cell-secreted Gal3 had a similar effect. The inhibition was reversed by lactose, and by the Gal3-neutralizing antibody B2C10, but not by sucrose or control IgG. Gal3 bound the E protein and reduced viral attachment and internalization. In silico docking was compatible with Gal3 engagement at both E glycosylation sites, with aggregate scores favoring Asn67. Knockdown of endogenous Gal3 enhanced, and overexpression suppressed, DENV-2 replication. Gal3 also amplified NF-κB activation and the expression of IL-6, IL-8, TNF-α and IL-1β, without altering type I interferon transcripts. In vivo , infected Gal3-KO neonates showed earlier mortality, higher brain viral loads and more severe neuropathology than wild-type mice. Conclusions Gal3 restricts DENV-2 by binding the viral envelope glycoprotein and reducing viral entry, and by enhancing NF-κB-dependent pro-inflammatory responses. Gal3 deficiency worsens disease in vivo , and Gal3 is a candidate host-directed target against dengue.

Virology Journal
Galectins and Cancer Biology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon